There is a lack of robust evidence to assess the strength of other treatment options
Objectives Sarcopenia , defined as an age-associated loss of skeletal muscle function and muscle mass , occurs in approximately 6 - 22 % of older adults .
This paper presents evidence -based clinical practice guidelines for screening , diagnosis and management of sarcopenia from the task force of the International Conference on Sarcopenia and Frailty Research ( ICSFR ) .
Validating the SARC-F: a suitable community screening tool for sarcopenia?
OBJECTIVES Using data from the Hong Kong Mr and Ms Os study , we vali date d the SARC-F against 3 consensus definitions of sarcopenia from Europe , Asia , and an international group , and compared the ability of all 4 measures to predict 4-year physical limitation , walking speed , and repeated chair st and s. DESIGN Prospect i ve cohort study . SETTING Hong Kong community . PARTICIPANTS Four thous and men and women living in the community . MEASUREMENTS A question naire regarding ability to carry a heavy load , walking , rising from a chair , climbing stairs , and falls frequency was administered . These questions were used to calculate the SARC-F score . Measurements , including appendicular muscle mass , were taken using dual-energy X-ray , grip strength using a dynamometer , 6-m gait speed , and time taken for repeated chair st and . Classification using the SARC-F score was compared using consensus panel criteria from international , European , and Asian sarcopenia working groups . The performance of all 4 methods was compared by examining the predictive ability for 4-year outcomes using ROC curve . RESULTS The SARC-F has excellent specificity but poor sensitivity for sarcopenia classification ; however , all 4 methods have comparable but modest predictive power for 4-year physical limitation . CONCLUSION The SARC-F may be considered a suitable tool for community screening for sarcopenia
There is a lack of robust evidence to assess the strength of other treatment options
Objectives Sarcopenia , defined as an age-associated loss of skeletal muscle function and muscle mass , occurs in approximately 6 - 22 % of older adults .
This paper presents evidence -based clinical practice guidelines for screening , diagnosis and management of sarcopenia from the task force of the International Conference on Sarcopenia and Frailty Research ( ICSFR ) .